Summer Street analyst Mark Landy reiterated a Buy rating and boosted his price target on CONMED (NASDAQ: CNMD) to $56.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE